Cargando…
New alternative to antidotes for novel oral anticoagulants and ticagrelor in the case of severe bleeding
Autores principales: | Honore, Patrick M., David, Christina, Attou, Rachid, Redant, Sebastien, Gallerani, Andrea, De Bels, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014763/ https://www.ncbi.nlm.nih.gov/pubmed/32046758 http://dx.doi.org/10.1186/s13054-020-2760-7 |
Ejemplares similares
-
Austrian recommendations for best clinical practice in case of haemorrhagic traumatic brain injury under platelet inhibitors or non-vitamin K antagonist oral anticoagulants: an additional therapeutic option to consider
por: Honore, Patrick M., et al.
Publicado: (2020) -
Procalcitonin to allow early detection of sepsis and multiple organ failure in severe multiple trauma: beware of some confounders
por: Honore, Patrick M., et al.
Publicado: (2020) -
Use of multiple laboratory tests including anti-factor Xa to optimally manage anticoagulation during ECMO
por: Honore, Patrick M., et al.
Publicado: (2020) -
Biomarkers to delineate bacteremia from candidemia remain a challenging issue
por: Honore, Patrick M., et al.
Publicado: (2020) -
In severe liver disease, citrate can be used safely: the question remains—by which mechanism
por: Honore, Patrick M., et al.
Publicado: (2020)